Epizyme: 2Q Earnings Snapshot

August 2, 2018

CAMBRIDGE, Mass. (AP) _ Epizyme Inc. (EPZM) on Thursday reported a loss of $29.1 million in its second quarter.

The Cambridge, Massachusetts-based company said it had a loss of 42 cents per share.

The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 53 cents per share.

The biopharmaceutical company posted revenue of $12 million in the period.

Epizyme shares have risen roughly 4 percent since the beginning of the year. The stock has climbed slightly more than 8 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EPZM at https://www.zacks.com/ap/EPZM

Update hourly